Douglas K. Frank
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Douglas K. Frank has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Bozena Szymkowiak
2 shared publicationsAzita S. Khorsandi
Radiology, Beth Israel Medical Center and The Institute for Head and Neck Cancer, New York, New York
1 shared publicationBruce E. Culliney
Department of Medical Oncology, Beth Israel Medical Center and The Institute for Head and Neck Cancer, New York, New York
1 shared publicationCynthia A. Hughes
1 shared publicationJonathan E. Sonne
Department of Otolaryngology, The New York Eye and Ear Infirmary, NY, USA
1 shared publicationKathleen W. Kinnally
New York University College of Dentistry, Division of Basic Sciences, New York, New York
1 shared publication
Latest Publications
- 1 November 2006
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 135 (5) , 736-743
Connexin expression and gap junctional intercellular communication in human squamous cell carcinoma of the head and neck
OBJECTIVE: Our laboratory is investigating the role that gap junction intercellular channels (composed of proteins called connexins) play in communicating apoptotic signals from therapeutically targeted squamous cell carcinoma of the head and neck (SCCHN) cells to adjacent, untreated, “bystander” cells (bystander effect). The nature of this research underscores the importance of delineating connexin expression patterns in SCCHN, and how this correlates with gap junctional intercellular communication (GJIC) and bystander effects. STUDY DESIGN: The GJIC activity of a diverse panel of SCCHN cell lines, as well as normal oral epithelial (NOE) cell controls was determined in vitro. These data were correlated with connexin expression patterns determined through connexin 43 and connexin 26 immunofluorescence. RESULTS: Cell lines with retained GJIC activity all expressed connexin 43 on the cell membrane. Cell lines that did not communicate microinjected lucifer yellow (lost GJIC activity) showed no connexin expression, either at the cell membrane or in the cytosol. Connexin 26 was not expressed in any of our SCCHN cell lines, whereas both connexin 43 and connexin 26 were expressed in the NOE cell controls. Furthermore, connexin 43 introduction into a GJIC (and connexin) deficient SCCHN cell line conferred no growth inhibitory effect. CONCLUSION: Connexin 43 expression correlates with retained GJIC in SCCHN in vitro. Connexin 26 may have a role as a tumor suppressor in SCCHN. SIGNIFICANCE: The data presented have relevance to our ongoing investigations of gap-junction mediated bystander effects in SCCHN and are being expanded to investigations on actual SCCHN tumor specimens.
- 1 November 2006
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 135 (5) , 736-743
Connexin expression and gap junctional intercellular communication in human squamous cell carcinoma of the head and neck
OBJECTIVE: Our laboratory is investigating the role that gap junction intercellular channels (composed of proteins called connexins) play in communicating apoptotic signals from therapeutically targeted squamous cell carcinoma of the head and neck (SCCHN) cells to adjacent, untreated, “bystander” cells (bystander effect). The nature of this research underscores the importance of delineating connexin expression patterns in SCCHN, and how this correlates with gap junctional intercellular communication (GJIC) and bystander effects. STUDY DESIGN: The GJIC activity of a diverse panel of SCCHN cell lines, as well as normal oral epithelial (NOE) cell controls was determined in vitro. These data were correlated with connexin expression patterns determined through connexin 43 and connexin 26 immunofluorescence. RESULTS: Cell lines with retained GJIC activity all expressed connexin 43 on the cell membrane. Cell lines that did not communicate microinjected lucifer yellow (lost GJIC activity) showed no connexin expression, either at the cell membrane or in the cytosol. Connexin 26 was not expressed in any of our SCCHN cell lines, whereas both connexin 43 and connexin 26 were expressed in the NOE cell controls. Furthermore, connexin 43 introduction into a GJIC (and connexin) deficient SCCHN cell line conferred no growth inhibitory effect. CONCLUSION: Connexin 43 expression correlates with retained GJIC in SCCHN in vitro. Connexin 26 may have a role as a tumor suppressor in SCCHN. SIGNIFICANCE: The data presented have relevance to our ongoing investigations of gap-junction mediated bystander effects in SCCHN and are being expanded to investigations on actual SCCHN tumor specimens.
- 10 June 2005
- Published by Wiley in Head & Neck
- Vol. 27 (9) , 794-800
Single-cell microinjection of cytochromec can result in gap junction-mediated apoptotic cell death of bystander cells in head and neck cancer
- 10 June 2005
- Published by Wiley in Head & Neck
- Vol. 27 (9) , 794-800
Single-cell microinjection of cytochromec can result in gap junction-mediated apoptotic cell death of bystander cells in head and neck cancer
- 1 June 2005
- Published by Wiley in The Laryngoscope
- Vol. 115 (6) , 1015-1020
Planned Neck Dissection after Concomitant Radiochemotherapy for Advanced Head and Neck Cancer
- 1 June 2005
- Published by Wiley in The Laryngoscope
- Vol. 115 (6) , 1015-1020
Planned Neck Dissection after Concomitant Radiochemotherapy for Advanced Head and Neck Cancer
- 1 July 2002
- Published by Elsevier in Surgical Oncology Clinics of North America
- Vol. 11 (3) , 589-606
Gene therapy for head and neck cancer
- 1 July 2002
- Published by Elsevier in Surgical Oncology Clinics of North America
- Vol. 11 (3) , 589-606
Gene therapy for head and neck cancer
- Open Access
- 1 December 2001
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 125 (6) , 670-672
Cervical Necrotizing Fasciitis as a Complication of Tonsillectomy
- 1 December 2001
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 125 (6) , 670-672
Open AccessCervical Necrotizing Fasciitis as a Complication of Tonsillectomy